PRP as an Adjunct for Rotator Cuff Tendinopathy
Analysis of placebo-controlled trials: variability in preparation and outcome measures limits generalizable conclusions.
ReadReview of published research on biologic adjuncts — platelet-rich plasma, mesenchymal stromal cells, and other supportive interventions — as an area of investigation within comprehensive management for musculoskeletal conditions.
This article synthesizes findings from randomized trials and observational studies examining the use of orthobiologics (PRP, bone marrow concentrate, and amniotic derivatives) as experimental adjuncts alongside conventional treatment for tendon disorders, cartilage lesions, and ligament injuries. Emphasis is placed on reported safety profiles and the heterogeneity of clinical outcomes.
Access reviewAnalysis of placebo-controlled trials: variability in preparation and outcome measures limits generalizable conclusions.
ReadCase series report on safety and feasibility; controlled studies are needed to assess efficacy relative to standard care.
ReviewCurrent evidence from phase I/II trials demonstrates a favorable safety profile; symptomatic benefit is under investigation.
ExploreSystematic review highlights limited low-bias evidence; adjunctive benefit is not consistently demonstrated.
SynopsisRetrospective cohort analysis: healing rates are comparable to historical controls; prospective RCTs are warranted.
AbstractPreclinical and early clinical evidence; current guidelines overview.
ReadEvidence review: adjunctive use, variable outcomes.
Safety and feasibility case series.
Phase I/II safety and exploratory outcomes.
Systematic review: insufficient evidence.
Schedule a consultation with our medical team to discuss how adjunctive regenerative medicine is being studied to support health goals. For additional information, you can also reach us directly via email or phone.
Email Us Call Us Contact Us to Learn More